Amyloid Aggregation on Lipid Bilayers and Its Impact on Membrane Permeability

Journal of Molecular Biology

Volumn 387, Issue 2, 2009, Pages 407-415

  Friedman, Ran ^a   Pellarin, Riccardo ^a   Caflisch, Amedeo ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Alzheimer's disease; coarse grained; diabetes type II; membrane leakage; molecular dynamics; protein aggregation

Indexed keywords

AMYLOID;

ARTICLE; COMPUTER SIMULATION; LIPID BILAYER; LIPID VESICLE; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN AGGREGATION;

EID: 61649121892     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.12.036     Document Type: Article

References (41)

1. Sunde M., and Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50 (1997) 123-159
2. Petkova A., Ishii Y., Balbach J., Antzutkin O., Leapman R., Delaglio F., and Tycko R. A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl Acad. Sci. USA 99 (2002) 16742-16747
3. Lührs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., Döbeli H., et al. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc. Natl Acad. Sci. USA 102 (2005) 17342-17347
4. Nelson R., Sawaya M., Balbirnie M., Madsen A., Riekel C., Grothe R., and Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 435 (2005) 773-778
5. Ferguson N., Becker J., Tidow H., Tremmel S., Sharpe T., Krause G., et al. General structural motifs of amyloid protofilaments. Proc. Natl Acad. Sci. USA 103 (2006) 16248-16253
6. Fändrich M. On the structural definition of amyloid fibrils and other polypeptide aggregates. Cell. Mol. Life Sci. 64 (2007) 2066-2078
7. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 (2002) 507-511
8. Lashuel H., and Lansbury P. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?. Q. Rev. Biophys. 39 (2006) 167-201
9. Haass C., and Selkoe D. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8 (2007) 101-112
10. Knight J., and Miranker A. Phospholipid catalysis of diabetic amyloid assembly. J. Mol. Biol. 341 (2004) 1175-1187
11. Gorbenko G.P., and Kinnunen P.K. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem. Phys. Lipids 141 (2006) 72-82
12. Kremer J.J., Sklansky D.J., and Murphy R.M. Profile of changes in lipid bilayer structure caused by beta-amyloid peptide. Biochemistry 40 (2001) 8563-8571
13. Volles M.J., Lee S.J., Rochet J.C., Shtilerman M.D., Ding T.T., Kessler J.C., and Lansbury P.T. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40 (2001) 7812-7819
14. Ambroggio E.E., Kim D.H., Separovic F., Barrow C.J., Barnham K.J., Bagatolli L.A., and Fidelio G.D. Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys. J. 88 (2005) 2706-2713
15. Aisenbrey C., Borowik T., Byström R., Bokvist M., Lindström F., Misiak H., et al. How is protein aggregation in amyloidogenic diseases modulated by biological membranes?. Eur. Biophys. J. 37 (2008) 247-255
16. Lopes D., Meister A., Gohlke A., Hauser A., Blume A., and Winter R. Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. Biophys. J. 93 (2007) 3132-3141
17. Chi E., Ege C., Winans A., Majewski J., Wu G., Kjaer K., and Lee K. Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide. Proteins 72 (2008) 1-24
18. Engel M.F.M., Khemtmourian L., Kleijer C., Meeldijk H., Jacobs J., Verkleij A., et al. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc. Natl Acad. Sci. USA 105 (2008) 6033-6038
19. Caflisch A. Computational models for the prediction of polypeptide aggregation propensity. Curr. Opin. Chem. Biol. 10 (2006) 437-444
20. Ma B., and Nussinov R. Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. Curr. Opin. Chem. Biol. 10 (2006) 445-452
21. Gsponer J., Haberthür U., and Caflisch A. The role of side-chain interactions in the early steps of aggregation: molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35. Proc. Natl Acad. Sci. USA 100 (2003) 5154-5159
22. 16-22 amyloid peptides into antiparallel β sheets. Structure 11 (2003) 295-307
23. Cecchini M., Rao F., Seeber M., and Caflisch A. Replica exchange molecular dynamics simulations of amyloid peptide aggregation. J. Chem. Phys. 121 (2004) 10748-10756
24. Hwang W., Zhang S., Kamm R., and Karplus M. Kinetic control of dimer structure formation in amyloid fibrillogenesis. Proc. Natl Acad. Sci. USA 101 (2004) 12916-12921
25. Urbanc B., Cruz L., Yun S., Buldyrev S.V., Bitan G., Teplow D.B., and Stanley H.E. In silico study of amyloid beta-protein folding and oligomerization. Proc. Natl Acad. Sci. USA 101 (2004) 17345-17350
26. López de la Paz M., de Mori G.M., Serrano L., and Colombo G. Sequence dependence of amyloid fibril formation: insights from molecular dynamics simulations. J. Mol. Biol. 349 (2005) 583-596
27. Cecchini M., Curcio R., Pappalardo M., Melki R., and Caflisch A. A molecular dynamics approach to the structural characterization of amyloid aggregation. J. Mol. Biol. 357 (2006) 1306-1321
28. Pellarin R., and Caflisch A. Interpreting the aggregation kinetics of amyloid peptides. J. Mol. Biol. 360 (2006) 882-892
29. Pellarin R., Guarnera E., and Caflisch A. Pathways and intermediates of amyloid fibril formation. J. Mol. Biol. 374 (2007) 917-924
30. Linse S., Cabaleiro-Lago C., Xue W., Lynch I., Lindman S., Thulin E., et al. Nucleation of protein fibrillation by nanoparticles. Proc. Natl Acad. Sci. USA 104 (2007) 8691-8696
31. Sharp J., Forrest J., and Jones R. Surface denaturation and amyloid fibril formation of insulin at model lipid-water interfaces. Biochemistry 41 (2002) 15810-15819
32. Jayasinghe S., and Langen R. Membrane interaction of islet amyloid polypeptide. Biochim. Biophys. Acta 1768 (2007) 2002-2009
33. Murphy R. Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins. Biochim. Biophys. Acta 1768 (2007) 1923-1934
34. Green J., Kreplak L., Goldsbury C., Li Blatter X., Stolz M., Cooper G., et al. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. J. Mol. Biol. 342 (2004) 877-887
35. Kayed R., Sokolov Y., Edmonds B., McIntire T., Milton S., Hall J., and Glabe C. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279 (2004) 46363-46366
36. Cohen F., and Kelly J. Therapeutic approaches to protein-misfolding diseases. Nature 426 (2003) 905-909
37. Shoval H., Lichtenberg D., and Gazit E. The molecular mechanisms of the anti-amyloid effects of phenols. Amyloid 14 (2007) 73-87
38. Jahn T.R., Parker M.J., Homans S.W., and Radford S.E. Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat. Struct. Mol. Biol. 13 (2006) 195-201
39. Cooke I., and Deserno M. Solvent-free model for self-assembling fluid bilayer membranes: stabilization of the fluid phase based on broad attractive tail potentials. J. Chem. Phys. 123 (2005) 224710
40. Ryckaert J.-P., Ciccotti G., and Berendsen H.J.C. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23 (1977) 327-341
41. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., and Karplus M. Charmm: a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4 (1983) 187-217